<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6738336</article-id><article-id pub-id-type="doi">10.3389/fmicb.2019.02044</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Adaption of an Episomal Antisense Silencing Approach for Investigation of the Phenotype Switch of <italic>Staphylococcus aureus</italic> Small-Colony Variants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schleimer</surname><given-names>Nina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/549824/overview"/></contrib><contrib contrib-type="author"><name><surname>Kaspar</surname><given-names>Ursula</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ballhausen</surname><given-names>Britta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fotiadis</surname><given-names>Sarah A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Streu</surname><given-names>Jessica M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kriegeskorte</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/170658/overview"/></contrib><contrib contrib-type="author"><name><surname>Proctor</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/156220/overview"/></contrib><contrib contrib-type="author"><name><surname>Becker</surname><given-names>Karsten</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/143943/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Institute of Medical Microbiology, University Hospital M&#x000fc;nster</institution>, <addr-line>M&#x000fc;nster</addr-line>, <country>Germany</country></aff><aff id="aff2"><sup>2</sup><institution>Departments of Medical Microbiology/Immunology and Medicine, School of Medicine and Public Health, University of Wisconsin</institution>, <addr-line>Madison, WI</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Lorena Tuchscherr, Jena University Hospital, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Stephen Peter Kidd, University of Adelaide, Australia; Andrew Edwards, Imperial College London, United Kingdom</p></fn><corresp id="c001">*Correspondence: Karsten Becker, <email>kbecker@uni-muenster.de</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>Present address: Ursula Kaspar, NRW Centre for Health, Department of Infectiology and Hygiene, Bochum, Germany; Britta Ballhausen, Federal Office of Consumer Protection and Food Safety (BVL), Berlin, Germany; Andr&#x000e9; Kriegeskorte, GlaxoSmithKline (GSK) Vaccines GmbH Marburg, Marburg, Germany</p></fn><fn fn-type="other" id="fn004"><p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>2044</elocation-id><history><date date-type="received"><day>07</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Schleimer, Kaspar, Ballhausen, Fotiadis, Streu, Kriegeskorte, Proctor and Becker.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Schleimer, Kaspar, Ballhausen, Fotiadis, Streu, Kriegeskorte, Proctor and Becker</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Staphylococcus aureus</italic> small-colony variants (SCVs) are associated with chronic, persistent, and relapsing courses of infection and are characterized by slow growth combined with other phenotypic and molecular traits. Although certain mechanisms have been described, the genetic basis of clinical SCVs remains often unknown. Hence, we adapted an episomal tool for rapid identification and investigation of putative SCV phenotype-associated genes via antisense gene silencing based on previously described Tn<italic>l0</italic>-encoded <italic>tet</italic>-regulatory elements. Targeting the SCV phenotype-inducing enoyl-acyl-carrier-protein reductase gene (<italic>fabI</italic>), plasmid pSN1-AS&#x02018;<italic>fabI</italic>&#x02019; was generated leading to antisense silencing, which was proven by pronounced growth retardation in liquid cultures, phenotype switch on solid medium, and 200-fold increase of antisense &#x02018;<italic>fabI</italic>&#x02019; expression. A crucial role of TetR repression in effective regulation of the system was demonstrated. Based on the use of anhydrotetracycline as effector, an easy-to-handle one-plasmid setup was set that may be applicable to different <italic>S. aureus</italic> backgrounds and cell culture studies. However, selection of the appropriate antisense fragment of the target gene remains a critical factor for effectiveness of silencing. This inducible gene expression system may help to identify SCV phenotype-inducing genes, which is prerequisite for the development of new antistaphylococcal agents and future alternative strategies to improve treatment of therapy-refractory SCV-related infections by iatrogenically induced phenotypic switch. Moreover, it can be used as controllable phenotype switcher to examine important aspects of SCV biology in cell culture as well as <italic>in vivo</italic>.</p></abstract><kwd-group><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>small-colony variant (SCV)</kwd><kwd>antisense silencing</kwd><kwd>phenotype switch</kwd><kwd>enoyl-acyl-carrier-protein reductase gene (<italic>fabI</italic>)</kwd><kwd><italic>tet</italic>-regulatory expression system</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source></award-group></funding-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="69"/><page-count count="9"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>The small-colony variant (SCV) phenotype represents a slow growing subpopulation of <italic>Staphylococcus aureus</italic> associated with chronic, persistent, and recurring infections, which are particularly difficult to diagnose and challenging in terms of treatment (<xref rid="B51" ref-type="bibr">Proctor et al., 2006</xref>; <xref rid="B60" ref-type="bibr">Vaudaux et al., 2006</xref>; <xref rid="B34" ref-type="bibr">Kahl et al., 2016</xref>). The colony morphology and physiological characteristics of SCVs differ widely from the WT, not only due to slower growth, pinpoint colonies, reduced or no pigmentation and hemolytic activity, respectively, but also in several biochemical traits such as altered expression of virulence factors, decreased respiration and coagulase activity as well as frequently by auxotrophism for hemin, menadione, thymidine, or fatty acids (<xref rid="B51" ref-type="bibr">Proctor et al., 2006</xref>; <xref rid="B54" ref-type="bibr">Seggewi&#x000df; et al., 2006</xref>; <xref rid="B37" ref-type="bibr">Kriegeskorte et al., 2011</xref>, <xref rid="B36" ref-type="bibr">2014</xref>; <xref rid="B50" ref-type="bibr">Proctor et al., 2014</xref>; <xref rid="B53" ref-type="bibr">Schleimer et al., 2018</xref>).</p><p>The identification of the genetic mechanisms leading to the phenotype switch are prerequisite to prevent SCV-related recurrence and chronic infection and to develop new antimicrobials not selecting for SCVs. Hitherto, however, only some phenotype switch-related genes and mechanisms were identified by <italic>in vitro</italic> generation of knockout mutants (including <italic>accC</italic>, <italic>accD</italic>, <italic>aroD</italic>, <italic>cspB</italic>, <italic>hemA, hemB, menA, menB, menD</italic>, <italic>plsX, sdhCAB</italic>, and <italic>thyA</italic>) and sequencing approaches (including <italic>accC</italic>, <italic>accD</italic>, <italic>aroB</italic>, <italic>aroC</italic>, <italic>aroD</italic>, <italic>ecfA</italic>, <italic>ecfT</italic>, <italic>fabF</italic>, <italic>fabI, hemA, hemB, hemC, hemD, hemE, hemG, hemH, menA, menB, menC, menE, menF, relA</italic>, <italic>stp</italic>, and <italic>thyA</italic>) (<xref rid="B62" ref-type="bibr">von Eiff et al., 1997</xref>; <xref rid="B7" ref-type="bibr">Bates et al., 2003</xref>; <xref rid="B52" ref-type="bibr">Schaaff et al., 2003</xref>; <xref rid="B15" ref-type="bibr">Chatterjee et al., 2008</xref>; <xref rid="B38" ref-type="bibr">Lannerg&#x000e5;rd et al., 2008</xref>; <xref rid="B19" ref-type="bibr">Duval et al., 2010</xref>; <xref rid="B21" ref-type="bibr">Gao et al., 2010</xref>; <xref rid="B22" ref-type="bibr">Gaupp et al., 2010</xref>; <xref rid="B49" ref-type="bibr">Parsons et al., 2011</xref>, <xref rid="B48" ref-type="bibr">2013</xref>, <xref rid="B47" ref-type="bibr">2014</xref>; <xref rid="B35" ref-type="bibr">K&#x000f6;ser et al., 2012</xref>; <xref rid="B63" ref-type="bibr">Wakeman et al., 2012</xref>; <xref rid="B25" ref-type="bibr">Hammer et al., 2013</xref>; <xref rid="B17" ref-type="bibr">Dean et al., 2014</xref>; <xref rid="B46" ref-type="bibr">Painter et al., 2015</xref>; <xref rid="B39" ref-type="bibr">Lin et al., 2016</xref>; <xref rid="B14" ref-type="bibr">Cao et al., 2017</xref>; <xref rid="B68" ref-type="bibr">Zhang et al., 2017</xref>; <xref rid="B8" ref-type="bibr">Bazaid et al., 2018</xref>; <xref rid="B24" ref-type="bibr">Giulieri et al., 2018</xref>; <xref rid="B53" ref-type="bibr">Schleimer et al., 2018</xref>; <xref rid="B61" ref-type="bibr">Vestergaard et al., 2018</xref>). Besides these SCVs triggered by mutational events restricted to one gene locus, SCVs being the consequence of combined mutations in two or more genes were also rarely described (<xref rid="B25" ref-type="bibr">Hammer et al., 2013</xref>; <xref rid="B13" ref-type="bibr">Bui and Kidd, 2015</xref>; <xref rid="B30" ref-type="bibr">James et al., 2019</xref>). Moreover, the differential expression of some key transcriptional regulators such as SigB and non-protein-coding RNAs (npcRNAs) were shown to contribute to the phenotype switch (<xref rid="B44" ref-type="bibr">Moisan et al., 2006</xref>; <xref rid="B1" ref-type="bibr">Abu-Qatouseh et al., 2010</xref>; <xref rid="B43" ref-type="bibr">Mitchell et al., 2013</xref>; <xref rid="B13" ref-type="bibr">Bui and Kidd, 2015</xref>; <xref rid="B58" ref-type="bibr">Tuchscherr et al., 2015</xref>). Nevertheless, the (potential) genetic mechanisms of several clinical SCVs remain unidentified and knockout mutant generation and sequencing approaches including whole genome sequencing (WGS) are time-consuming. Moreover, selective disruption of genes essential for growth is not feasible. Aggravating the analysis of clinical SCVs so far, indubitable identification of genes causative for the phenotype switch is only possible for stable SCVs that already underwent mutational adaption and by comparison with a revertant phenotype that spontaneously emerged from the SCV phenotype (<xref rid="B10" ref-type="bibr">Becker et al., 2006</xref>; <xref rid="B53" ref-type="bibr">Schleimer et al., 2018</xref>). Besides the rarely isolated stable clinical SCVs, <italic>in vitro</italic> selection for stable SCVs mandatory for WGS as well as for transcriptomics and proteomics can be performed by cultivation in the presence of sublethal concentrations of certain antibiotics (e.g., aminoglycosides) (<xref rid="B4" ref-type="bibr">Balwit et al., 1994</xref>) or by serially passaging bacteria in the presence of HeLa cells using modified gentamicin protection assays (<xref rid="B41" ref-type="bibr">McLean et al., 2019</xref>). By using these methods, however, the SCV-selective mutations only occur in the corresponding drug target genes or genes essential for antibiotic uptake (<xref rid="B52" ref-type="bibr">Schaaff et al., 2003</xref>; <xref rid="B41" ref-type="bibr">McLean et al., 2019</xref>). Further approaches selecting for a stable SCV phenotype include a chemostat to generate steady-state growth conditions with low nutrients and low growth rate for a prolonged time and with specific chemical stress (<xref rid="B13" ref-type="bibr">Bui and Kidd, 2015</xref>; <xref rid="B12" ref-type="bibr">Bui et al., 2015</xref>). Although this is an adequate method, it is also time-consuming and not applicable in every laboratory. Thus, there is an urgent need for simpler, faster, and more cost-effective methods to identify genes that trigger the phenotype switch upon mutational or transcriptional inactivation or downregulation.</p><p>Inducible gene expression systems comprising repressor and operator regulatory elements have been reported for use in the genus <italic>Staphylococcus</italic> for selectively controlling the (over)expression of genes (<xref rid="B64" ref-type="bibr">Wieland et al., 1995</xref>; <xref rid="B32" ref-type="bibr">Ji et al., 1999</xref>; <xref rid="B31" ref-type="bibr">Jana et al., 2000</xref>; <xref rid="B27" ref-type="bibr">Helle et al., 2011</xref>). Amongst these, tetracycline- (Tc) or anhydrotetracycline (ATc)-inducible expression plasmids comprising improved elements originating from the transposable element Tn<italic>10</italic> were used not only for overexpression, but also for regulated antisense silencing of distinct genes (<xref rid="B32" ref-type="bibr">Ji et al., 1999</xref>, <xref rid="B33" ref-type="bibr">2004</xref>; <xref rid="B55" ref-type="bibr">Stary et al., 2010</xref>; <xref rid="B27" ref-type="bibr">Helle et al., 2011</xref>). This study focused on the adaption of the expression plasmid pRAB11 (<xref rid="B27" ref-type="bibr">Helle et al., 2011</xref>) for the identification of genes potentially triggering the phenotype switch from WT to SCV. Therefore, we developed an ATc-inducible antisense approach outlined in <xref ref-type="fig" rid="F1">Figure 1</xref>. This <italic>tet</italic>-regulatory system is based on autoregulated expression of the repressor TetR, which is responsible for the adequate regulation of a target gene. TetR attaches to the cognate operator sequences within both its own promoter and in the divergently located promoter of the target gene, thus, inhibiting the transcription of the target gene (<xref rid="B42" ref-type="bibr">Meier et al., 1988</xref>). Upon binding of the effector, TetR undergoes a conformational change and the detachment from the operator proceeds (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Model of episomal ATc-inducible antisense silencing in <italic>S. aureus</italic> using plasmid pSN1. <bold>(A)</bold> In the absence of effector ATc, constitutively expressed homodimer TetR (gray ellipses) binds to the cognate operator sequences consequently inhibiting gene transcription via promoter P<italic><sub><italic>xyl/tet</italic></sub></italic> and negatively regulating the rate of transcription of <italic>tetR</italic>. <bold>(B)</bold> Gene expression proceeds upon induction with ATc (red circles) that results in a conformational change of TetR followed by detachment from the cognate operator sequences. Hybridization of transcribed antisense (AS)-RNA to the complementary mRNA is presumptively followed by degradation and silencing of the respective gene maybe resulting in an SCV phenotype. <bold>(C)</bold> Sequence of promoter P<sub><italic>R</italic></sub><sup>&#x02217;</sup> according to <xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen (1990)</xref>; extended Shine-Dalgarno sequence of <italic>tetR</italic> is indicated with a gray box and operator sequence <italic>tetO</italic><sub>1</sub> with a black box, respectively. The consensus sequence of the &#x02013;10 site of promoter P<italic><sub><italic>tetR</italic></sub></italic> of plasmid pRAB11 is shown below the &#x02013;10 sequence of P<sub><italic>R</italic></sub><sup>&#x02217;</sup> with the changed bases given in bold and underlined.</p></caption><graphic xlink:href="fmicb-10-02044-g001"/></fig><p>Using the further improved shuttle plasmid pSN1, silencing of the SCV phenotype-related gene <italic>fabI</italic> (encodes for enoyl-acyl-carrier-protein reductase) via production of antisense RNA was performed in a one-plasmid setup. Application of this type of episomal silencing system may provide an easy-to-use and fast tool for the identification of phenotype switch-related genes. The identified genes producing the SCV phenotype will not only allow the screening of clinical SCV isolates, in particular those with undefined auxotrophy, for mutations in these genes by simple Sanger sequencing. Furthermore, knockout mutant generation of the identified genes may also contribute to the identification of possible new auxotrophies and thus to the characterization of undefined SCV types, further simplifying the identification of SCVs. Another advantage of the pSN1 tool is that its inducer ATc is able to penetrate cell membranes. Thus, it may not only help to develop future alternative treatment options of therapy-refractory SCV-related infections, e.g., by iatrogenically induced phenotypic switch, but will also offer the opportunity to monitor the effects and consequences of the switching process on the host cell, organs, and the host organism. Finally, this tool may enable the fast suitability analysis of potential new drug target genes regarding their influence on an adverse phenotype switch to the SCV.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2.SS1"><title>Bacterial Strains and Plasmids, Growth Conditions, and Antibiotics</title><p>All strains and plasmids used are listed in <xref rid="T1" ref-type="table">Table 1</xref>. <italic>Escherichia coli</italic> cells were cultivated and grown at 37&#x000b0;C in liquid or on solid Luria-Bertani medium (LB; Becton Dickinson, Franklin Lakes, NJ, United States). <italic>S. aureus</italic> strains were grown at 37&#x000b0;C in tryptic soy broth/agar (TSB/TSA; Becton Dickinson) or on Columbia blood agar (BBL<sup>TM</sup> Columbia agar with 5% sheep blood; Becton Dickinson). All liquid cultures were incubated with shaking at 160 rpm in 10 or 50 mL TSB in 100- or 500-mL glass baffled flasks, respectively. Ampicillin (Sigma-Aldrich, St. Louis, MO, United States) was used at a final concentration of 100 &#x003bc;g/mL for selection of <italic>E. coli.</italic> Chloramphenicol (AppliChem, Darmstadt, Germany) was used at a final concentration of 10 &#x003bc;g/mL for selection of <italic>S. aureus</italic>. ATc (IBA Lifesciences, G&#x000f6;ttingen, Germany) was purchased in dry chemical form, prepared as 10 mM stock solution in 70% ethanol and used as effector agent at a final concentration of 0.4 &#x003bc;M.</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Bacterial strains and plasmids with their precursors used in this study.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Strain or plasmid</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Description</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Source or references</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>S. aureus</italic> strains</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NCTC8325-4</td><td valign="top" align="left" rowspan="1" colspan="1">NCTC8325 derivative; <italic>agr</italic><sup>+</sup>; 11-bp deletion in <italic>rsbU</italic>; cured of three prophages</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B45" ref-type="bibr">Novick, 1967</xref>; <xref rid="B28" ref-type="bibr">Herbert et al., 2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RN4220</td><td valign="top" align="left" rowspan="1" colspan="1">NCTC8325-4 derivative; <italic>agr</italic><sup>&#x02013;</sup>; 11-bp deletion in <italic>rsbU</italic>; cured of three prophages; MNNG: r<sup>&#x02013;</sup>m<sup>&#x02013;</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B29" ref-type="bibr">Iordanescu and Surdeanu, 1976</xref>; <xref rid="B28" ref-type="bibr">Herbert et al., 2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SA113</td><td valign="top" align="left" rowspan="1" colspan="1">NCTC8325 derivative; <italic>agr</italic><sup>&#x02013;</sup>; 11-bp deletion in <italic>rsbU</italic>; point mutation in <italic>tcaR</italic>; three prophages, &#x003a6;11, &#x003a6;12, and &#x003a6;13; MNNG: r<sup>&#x02013;</sup>m<sup>&#x02013;</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B29" ref-type="bibr">Iordanescu and Surdeanu, 1976</xref>; <xref rid="B28" ref-type="bibr">Herbert et al., 2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SAS32/1</td><td valign="top" align="left" rowspan="1" colspan="1">SA113 pRAB11</td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SAS99/1</td><td valign="top" align="left" rowspan="1" colspan="1">SA113 pSN1</td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SAS118/2</td><td valign="top" align="left" rowspan="1" colspan="1">SA113 pSN1-AS&#x02018;<italic>fabI</italic>&#x02019;</td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic> strain</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">One shot<sup>TM</sup> Top10</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic> K-12 derivative; F- <italic>mcrA</italic> &#x00394;(<italic>mrr-hsd</italic>RMS-<italic>mcr</italic>BC) &#x003a6;80<italic>lac</italic>Z&#x00394;M15 &#x00394; <italic>lac</italic>X74 <italic>rec</italic>A1 <italic>ara</italic>D139 &#x00394;(<italic>araleu</italic>)7697 <italic>gal</italic>U <italic>gal</italic>K <italic>rps</italic>L (StrR) <italic>end</italic>A1 <italic>nup</italic>G</td><td valign="top" align="left" rowspan="1" colspan="1">Invitrogen/Thermo Fisher Scientific</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Plasmids</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pCPP-3<sup>1</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>B. subtilis</italic> shuttle plasmid; derived from plasmids pBR322, pUBll0 and pC194; <italic>neo</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B5" ref-type="bibr">Band et al., 1983</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pWH353<sup>1</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>B. subtilis</italic> shuttle plasmid; pCPP-3 derivative carrying an 800-bp fragment comprising Tn<italic>10</italic> derived elements <italic>tetR</italic> (encoding the TetR repressor) and P<sub><italic>R</italic></sub><sup>&#x02217;</sup> (mutant <italic>tetR</italic> promoter with poly-A block and improved &#x02212;35 site), and the divergent P<italic><sub><italic>xyl/tet</italic></sub></italic> fusion promoter from <italic>B. subtilis</italic> with 1x <italic>tetO</italic>; <italic>neo</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen, 1990</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pSK236<sup>1</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid with pUC19 cloned into the <italic>Hin</italic>dIII site of pC194; <italic>bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1">(unpublished data) <xref rid="B57" ref-type="bibr">Tinsley and Khan, 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pALC2073<sup>1</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid; pSK236 derivative with 800-bp fragment from pWH353 comprising <italic>tetR</italic>, P<sub><italic>R</italic></sub><sup>&#x02217;</sup>, and P<italic><sub><italic>xyl/tet</italic></sub></italic> with 1x <italic>tetO</italic> (cloned into the <italic>Pst</italic>I and <italic>Sma</italic>I sites); <italic>bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B6" ref-type="bibr">Bateman et al., 2001</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pRMC2<sup>1</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid; pALC2073 derivative with mutated &#x02212;10 sequence within the <italic>tetR</italic> promoter (5&#x02032;-ta<underline>g</underline> a<underline>g</underline> t-3&#x02032;&#x02192; 5&#x02032;-ta<underline>t</underline> a<underline>a</underline> t-3&#x02032;; P<italic><sub><italic>tetR</italic></sub></italic>) and extended MCS (<italic>Kpn</italic>I, <italic>Hpa</italic>I, <italic>Bgl</italic>II, <italic>Sac</italic>I/<italic>Ban</italic>II, and <italic>Eco</italic>RI); <italic>tetR</italic>, P<italic><sub><italic>tetR</italic></sub></italic>, and P<italic><sub><italic>xyl/tet</italic></sub></italic> with1x <italic>tetO; bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B16" ref-type="bibr">Corrigan and Foster, 2009</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pRAB11<sup>2</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid; pRMC2 derivative with <italic>tetR</italic>, P<italic><sub><italic>tetR</italic></sub></italic>, and P<italic><sub><italic>xyl/tet</italic></sub></italic> with 2x <italic>tetO</italic>; <italic>bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B27" ref-type="bibr">Helle et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pEX-A2</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic> standard plasmid; pUC ori; <italic>bla</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Eurofins Genomics</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pEX-A2-P<sub><italic>R</italic></sub><sup>&#x02217;</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic> standard plasmid; pEX-A2 derivative with 90-bp synthetic fragment comprising P<sub><italic>R</italic></sub><sup>&#x02217;</sup> framed by <italic>Xba</italic>I and <italic>Xho</italic>I; <italic>bla</italic></td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pSN1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid; pRAB11 derivative with <italic>tetR</italic>, P<sub><italic>R</italic></sub><sup>&#x02217;</sup>, and P<italic><sub><italic>xyl/tet</italic></sub></italic> with 2x <italic>tetO</italic>; <italic>bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pSN1-AS&#x02018;<italic>fabI</italic>&#x02019;</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. coli</italic>/<italic>Staphylococcus</italic> shuttle plasmid; pSN1 with 382-bp fragment of <italic>fabI</italic> cloned in antisense orientation in the <italic>Eco</italic>RI and <italic>Kpn</italic>I sites downstream of P<italic><sub><italic>xyl/tet</italic></sub></italic> with 2x <italic>tetO</italic>; <italic>bla cat</italic></td><td valign="top" align="left" rowspan="1" colspan="1">This study</td></tr></tbody></table><table-wrap-foot><attrib><italic><sup>1</sup>Precursor plasmids of pRAB11. <sup>2</sup>Kindly provided by Ralph Bertram, Department of Microbial Genetics, University of T&#x000fc;bingen, T&#x000fc;bingen, Germany.</italic></attrib></table-wrap-foot></table-wrap></sec><sec id="S2.SS2"><title>Genetic Manipulation in <italic>E. coli</italic> and <italic>S. aureus</italic></title><p>One Shot<sup>TM</sup> Top10 chemically competent <italic>E. coli</italic> cells (Invitrogen/Thermo Fisher Scientific, Waltham, MA, United States) were used for propagation and cloning experiments. Transformation of <italic>E. coli</italic> was performed using standard techniques (<xref rid="B26" ref-type="bibr">Hanahan, 1983</xref>) and plasmid DNA cloned in <italic>E. coli</italic> was isolated with the Qiagen Plasmid Mini kit (Qiagen, Venlo, Netherlands) and used to transform restriction-deficient <italic>S. aureus</italic> RN4220 by electroporation (<xref rid="B2" ref-type="bibr">Augustin and G&#x000f6;tz, 1990</xref>). Subsequently, plasmid DNA was introduced into <italic>S. aureus</italic> SA113 by electroporation. All constructed plasmids were verified after each cloning step via standard-PCR amplification using plasmid-specific oligonucleotides pSN1-F (5&#x02032;-CTGGGCGAGTTTACGGGTTG-3&#x02032;) and pSN1-R (5&#x02032;-CAC ATGCAGCTCCCGGAGAC-3&#x02032;) covering the <italic>tet</italic>-regulatory elements and, if present, the <italic>fabI</italic> fragment. The reaction conditions for standard-PCRs using Taq DNA polymerase (Segenetic, Borken, Germany) were 4 min initial denaturation at 95&#x000b0;C followed by 31 cycles of (i) denaturation at 95&#x000b0;C for 30 s, (ii) annealing at 58&#x000b0;C for 30 s, and (iii) extension at 72&#x000b0;C for 1 min. Final extension was performed at 72&#x000b0;C for 10 min. Analysis of PCR and restriction products was performed by agarose gel electrophoresis and purification using the QIAquick PCR Purification kit (Qiagen). This was followed by Sanger sequencing (Eurofins Genomics, Ebersberg, Germany). Restriction enzymes used for cloning were obtained from New England Biolabs (Frankfurt am Main, Germany). Genomic DNA of NCTC8325-4 was extracted after lysostaphin treatment (20 &#x003bc;g/mL, 1 h, 37&#x000b0;C) (Wak-Chemie Medical, Steinbach, Germany) using the QIAamp DNA Mini kit (Qiagen). Secondary sequence structure prediction was performed using the Mfold web server (<xref rid="B69" ref-type="bibr">Zuker, 2003</xref>) with default settings. The structure exhibiting the lowest &#x00394;G was used for further analyses.</p></sec><sec id="S2.SS3"><title>Construction of Plasmids for Episomal Silencing of Gene fabI</title><p>To introduce two base substitutions within the &#x02212;10 site of promoter P<italic><sub><italic>tetR</italic></sub></italic> in pRAB11, a 90-bp sequence comprising promoter P<sub><italic>R</italic></sub><sup>&#x02217;</sup> (<xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen, 1990</xref>) framed by <italic>Xba</italic>I and <italic>Xho</italic>I sites was chemically synthesized and cloned into the multiple cloning site (MCS) of pEX-A2 (Eurofins Genomics) to yield pEX-A2-P<sub><italic>R</italic></sub><sup>&#x02217;</sup>. Since restriction via <italic>Xba</italic>I and <italic>Xho</italic>I was not practicable, P<sub><italic>R</italic></sub><sup>&#x02217;</sup> was amplified with oligonucleotides P<sub><italic>R</italic></sub><sup>&#x02217;</sup>-F (5&#x02032;-GCGC<bold>TCTAGA</bold>CATCATTAATTCCT-3&#x02032;) and P<sub><italic>R</italic></sub><sup>&#x02217;</sup>-R (5&#x02032;-CGCG<bold>CTCGAG</bold>GGGATCCAAATAAA-3&#x02032;) (restriction sites are written in bold) from pEX-A2-P<sub><italic>R</italic></sub><sup>&#x02217;</sup> via standard PCR followed by restriction with <italic>Xba</italic>I and <italic>Xho</italic>I. For the construction of pSN1, the <italic>Xba</italic>I-<italic>Xho</italic>I synthetic P<sub><italic>R</italic></sub><sup>&#x02217;</sup> sequence (see <xref ref-type="fig" rid="F1">Figure 1C</xref>) was cloned into pRAB11 replacing P<italic><sub><italic>tetR</italic></sub></italic> and generating pSN1 that was transformed to <italic>S. aureus</italic> SA113 to generate SAS99/1.</p><p>For the construction of plasmid pSN1-AS&#x02018;<italic>fabI</italic>&#x02019;, a 382-bp fragment of the N-terminal region of the <italic>fabI</italic> gene (SAOUHSC_00947, corresponding to nucleotides 18 to 399) was amplified from genomic DNA of NCTC8325-4 using oligonucleotides <italic>fabI</italic>-AS-F-<italic>Eco</italic>RI (5&#x02032;-GCGC<bold>GAATTC</bold>CAAAACATATGTCATCATGGGAAT-3&#x02032;) and <italic>fabI</italic>-AS-R-<italic>Kpn</italic>I (5&#x02032;-GCGC<bold>GGTACC</bold>TTTAGCTTCATGAG CCACAAT-3&#x02032;) (restriction sites are written in bold) and the <italic>Eco</italic>RI/<italic>Kpn</italic>I-digested PCR product was ligated in antisense orientation downstream of the P<italic><sub><italic>xyl/tet</italic></sub></italic> promotor-operator fusion into the <italic>Eco</italic>RI and <italic>Kpn</italic>I sites within the MCS of pSN1. The verified construct was subsequently transformed into SA113 yielding SAS118/2. Further <italic>fabI</italic> fragments with 75-bp, 100-bp, 150-bp, 200-bp, and 300-bp in size originating from different regions of <italic>fabI</italic> with and without the Shine-Dalgarno sequence were additionally amplified (used oligonucleotides and characteristics of each antisense &#x0201c;<italic>fabI</italic>&#x0201d; fragment are listed in <xref ref-type="supplementary-material" rid="TS1">Supplementary Tables S1, S2</xref>, respectively), cloned into plasmid pSN1, and transformed into SA113.</p></sec><sec id="S2.SS4"><title>Growth Curve Analysis and <italic>tet</italic>-Regulated Antisense Silencing</title><p>For growth analysis applying gene silencing due to induction of antisense transcription of the <italic>fabI</italic> fragment, <italic>S. aureus</italic> SA113, SAS32/1, SAS99/1, and SAS118/2 were inoculated in 50 mL TSB (Becton Dickinson) containing chloramphenicol where appropriate. Concurrently, strains were inoculated as stated with and without ATc (IBA). The strains were cultured at 37&#x000b0;C on a rotary shaker at 160 rpm in 500-mL glass baffled flasks. Aliquots were taken every hour to determine the optical density (OD<sub>578</sub><sub><italic>nm</italic></sub>).</p><p>Furthermore, TSA (Becton Dickinson) containing 0.2 &#x003bc;M and 0.4 &#x003bc;M ATc (IBA) was used for examination of the colony phenotype upon gene silencing. Therefore, samples were adjusted to McFarland 0.5 (in 0.9% NaCl), diluted (10<sup>&#x02013;4</sup>) and 100 &#x003bc;l were streaked on agar that was then incubated overnight at 37&#x000b0;C. The different colony phenotypes, macroscopically divided into micro-SCVs, mini-SCVs, SCVs, and WTs, were counted and their percentage was calculated (mean of three independent measurements).</p></sec><sec id="S2.SS5"><title>Gene Expression Analysis via Real-Time Quantitative PCR</title><p>Levels of <italic>fabI</italic> transcripts at several time points from three independent experiments were determined by real-time qPCR (run in triplicates). Cells were harvested at 2 h, 4 h, and 7 h during growth curve analysis. Harvesting, RNA isolation, DNase treatment, reverse transcription, and qPCR were performed as previously described (<xref rid="B3" ref-type="bibr">Ballhausen et al., 2014</xref>) with the exception of minor deviations in the qPCR protocol consisting of 40 cycles of 10 s at 95&#x000b0;C, 10 s at 55&#x000b0;C, and 30 s at 72&#x000b0;C. 16S rRNA (oligonucleotides, 16S-rRNA-1 and 16S-rRNA-2) (<xref rid="B3" ref-type="bibr">Ballhausen et al., 2014</xref>) and <italic>gyrB</italic> (<italic>gyrB</italic>-1, 5&#x02032;-AATTGAAGCAGGCTATGTGT-3&#x02032; and <italic>gyrB</italic>-2, 5&#x02032;-ATAGACCATTTTGGTGTTGG-3&#x02032;) were used as references. Specific oligonucleotides used for determination of expression of the 382-bp <italic>fabI</italic> fragment were <italic>fabI</italic>-RT-1 (5&#x02032;-AAATCAACCAGAAGCGCACT-3&#x02032;) and <italic>fabI</italic>-RT-2 (5&#x02032;-ACAAGAAGCCTTCACGTGAA-3&#x02032;) both binding within the antisense fragment. The relative expression was calculated using the software CFX Manager v 3.1 (Bio-Rad Laboratories, Hercules, CA, United States) applying inter-run calibration. Expression values were normalized to strain SAS99/1 (2 h) harboring the empty pSN1 (control) to exclude chromosomal <italic>fabI</italic> expression.</p></sec></sec><sec id="S3"><title>Results and Discussion</title><p>Since SCV-caused infections are difficult to treat, it is of major interest to identify and characterize those genes, which are involved in the phenotypic switch from the WT to the SCV phenotype. However, the approaches used so far for this purpose are expensive, time-consuming, and/or difficult in handling. Moreover, clinically derived strain pairs consisting of both stable SCVs and revertant WTs are prerequisites. Therefore, this study focused on the generation of an easy-to-handle genetic tool for the rapid identification of SCV phenotype generation-related genes.</p><p>In our study, we adapted the Tn<italic>10</italic>-encoded Tc- or ATc-inducible <italic>tet-</italic>regulated repressor-operator expression system, which was first described in <italic>E. coli</italic> and then modified in several ways to meet the different requirements for Gram-positive bacteria (reviewed in <xref rid="B11" ref-type="bibr">Bertram and Hillen, 2008</xref>). For episomal antisense silencing of phenotype-related genes in <italic>S. aureus</italic> (see <xref ref-type="fig" rid="F1">Figure 1</xref>), we employed plasmid pRAB11 (<xref rid="B27" ref-type="bibr">Helle et al., 2011</xref>) containing the <italic>tet</italic>-regulatory elements <italic>tetR</italic> (encodes the repressor), its enhanced autoregulated promoter P<italic><sub><italic>tetR</italic></sub></italic> (<xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen, 1990</xref>; <xref rid="B16" ref-type="bibr">Corrigan and Foster, 2009</xref>), and the divergently located promoter-operator fusion P<italic><sub><italic>xyl/tet</italic></sub></italic> with two <italic>tetO</italic> sequences (<xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen, 1990</xref>; see <xref ref-type="fig" rid="F1">Figure 1</xref>). Since for fatty acid metabolism-related gene <italic>fabI</italic>, mutations were already shown to be responsible for the phenotype switch to the SCV (<xref rid="B8" ref-type="bibr">Bazaid et al., 2018</xref>), we exemplarily used this gene in our experiments. Initial experiments to determine the suitability of pRAB11 unexpectedly revealed pronounced growth retardation for strain SAS32/1 carrying the empty pRAB11 upon induction with the effector ATc (<xref ref-type="fig" rid="F2">Figure 2</xref>). ATc represents a derivative of Tc, but since growth of SA113 in ATc-containing TSB was not affected, its low antibiotic activity (<xref rid="B18" ref-type="bibr">Degenkolb et al., 1991</xref>) was not responsible for the slow growth phenomenon. During generation of plasmid pRAB11 for the use in Gram-positive bacteria, several modifications were performed (see <xref rid="T1" ref-type="table">Table 1</xref>; <xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen, 1990</xref>; <xref rid="B6" ref-type="bibr">Bateman et al., 2001</xref>; <xref rid="B16" ref-type="bibr">Corrigan and Foster, 2009</xref>; <xref rid="B27" ref-type="bibr">Helle et al., 2011</xref>). Amongst these, adaptation of the &#x02212;10 sequence within the <italic>tetR</italic>-driving promoter P<sub><italic>R</italic></sub><sup>&#x02217;</sup> formally designed by <xref rid="B23" ref-type="bibr">Geissend&#x000f6;rfer and Hillen (1990)</xref> resulted in the consensus sequence (5&#x02032;-ta<bold><underline>g</underline></bold> a<bold><underline>g</underline></bold> t-3&#x02032;&#x02192; 5&#x02032;-ta<bold><underline>t</underline></bold> a<bold><underline>a</underline></bold> t-3&#x02032;) (<xref rid="B16" ref-type="bibr">Corrigan and Foster, 2009</xref>), but unintentionally led to a disruption of its palindromic <italic>tetO</italic><sub>1</sub> sequence (see <xref ref-type="fig" rid="F1">Figure 1C</xref>) and therefore, presumptively resulted in increased amounts of TetR due to loss of its negative regulation (<xref rid="B55" ref-type="bibr">Stary et al., 2010</xref>). Whilst increased amounts of TetR provide improved repression for P<italic><sub><italic>xyl/tet</italic></sub></italic> promotor constructs harboring only one <italic>tetO</italic> (<xref rid="B16" ref-type="bibr">Corrigan and Foster, 2009</xref>) in the uninduced state, these high TetR concentrations may be toxic to the cells (<xref rid="B40" ref-type="bibr">Lutz and Bujard, 1997</xref>) as the unbound TetR homodimers are freely available in the induced state. Furthermore, since induction of the P<italic><sub><italic>xyl/tet</italic></sub></italic> promoter may be negatively affected by overexpression of TetR (<xref rid="B20" ref-type="bibr">Ehrt et al., 2005</xref>), we adapted the system by restoring the <italic>tetO</italic><sub>1</sub> sequence within the TetR promoter generating plasmid pSN1. <italic>S. aureus</italic> cells harboring pSN1 (SAS99/1) showed no signs of growth retardation in presence of ATc (<xref ref-type="fig" rid="F3">Figure 3</xref>) presumptively linked to the fact that, due to the restored <italic>tetO</italic><sub>1</sub>, the negatively controlled transcription of <italic>tetR</italic> by TetR as in its original state (<xref rid="B66" ref-type="bibr">Yang et al., 1976</xref>; <xref rid="B9" ref-type="bibr">Beck et al., 1982</xref>; <xref rid="B65" ref-type="bibr">Wissmann et al., 1988</xref>) is reconstituted.</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Effect of pRAB11-derived TetR on growth of <italic>S. aureus</italic> strain SAS32/1. <italic>S. aureus</italic> wild type strain SA113 without pRAB11 was used as control. Filled symbols indicate the presence of 0.4 &#x003bc;M anhydrotetracycline (ATc).</p></caption><graphic xlink:href="fmicb-10-02044-g002"/></fig><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Effect of episomal &#x02018;<italic>fabI</italic>&#x02019; antisense expression controlled by pSN1-derived TetR in <italic>S. aureus</italic> SAS118/2 carrying pSN1-AS&#x02018;<italic>fabI</italic>&#x02019; (gray symbols). Black symbols indicate growth curves of <italic>S. aureus</italic> control strains SA113 and SAS99/1 (SA113 carrying empty pSN1). Filled symbols indicate the presence of 0.4 &#x003bc;M anhydrotetracycline (ATc).</p></caption><graphic xlink:href="fmicb-10-02044-g003"/></fig><p>For episomal antisense silencing, a 382-bp fragment of the gene <italic>fabI</italic> mostly congruent with fragments used before (<xref rid="B33" ref-type="bibr">Ji et al., 2004</xref>; <xref rid="B55" ref-type="bibr">Stary et al., 2010</xref>) was cloned downstream of promoter P<italic><sub><italic>xyl/tet</italic></sub></italic> in pSN1. Induction with ATc resulted in distinct retardation of growth (<xref ref-type="fig" rid="F3">Figure 3</xref>) as shown before with chromosomally encoded <italic>tetR</italic> (<xref rid="B55" ref-type="bibr">Stary et al., 2010</xref>) as well as for episomal silencing with a plasmid harboring a leaky (<xref rid="B67" ref-type="bibr">Zhang et al., 2000</xref>) one-<italic>tetO</italic>-version that was induced with Tc (<xref rid="B33" ref-type="bibr">Ji et al., 2004</xref>). Phenotypic characterization of <italic>fabI</italic> antisense silencing on solid agar revealed colonies exhibiting the SCV phenotype only upon induction with ATc (<xref ref-type="fig" rid="F4">Figure 4</xref>). The SCV phenotype was more pronounced on agar containing 0.4 &#x003bc;M ATc than on agar with 0.2 &#x003bc;M ATc. However, on agar with 0.4 &#x003bc;M ATc, SCVs were heterogeneous in size with 74.83% micro-SCVs, 19.14% mini-SCVs, and 3.73% SCVs, respectively. This differentiation into different SCV phenotypes despite the same treatment and environmental conditions is a phenomenon known for SCVs and implicates an adaption strategy during the infection and persistence process (<xref rid="B59" ref-type="bibr">Tuchscherr et al., 2011</xref>). It was therefore expected that the bacterial cells have the ability to react slightly different to the silencing of a particular gene and the environmental conditions. Unaffected WT cells remained for both ATc concentrations at a ratio of 1.17% for 0.2 &#x003bc;M and 2.30% for 0.4 &#x003bc;M ATc. This may indicate that some of the cells were able to escape induction with ATc, which needs to be further investigated. Since qPCR showed a considerably elevated expression of antisense &#x02018;<italic>fabI</italic>&#x02019; only for strain SAS118/2 in the induced state (&#x0223c; 200-fold increase compared to induced control strain SAS99/1, both measured after 2 h of growth) (<xref ref-type="fig" rid="F5">Figure 5</xref>), this indicates functional silencing due to pSN1-derived antisense expression.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Phenotypic effect of episomal &#x02018;<italic>fabI</italic>&#x02019; antisense silencing controlled by pSN1-derived TetR in <italic>S. aureus</italic> on TSA agar with and without anhydrotetracycline (ATc). The upper row shows control strain SAS99/1 harboring the empty plasmid pSN1 and the lower row shows &#x02018;<italic>fabI</italic>&#x02019;-carrying strain SAS118/2. Phenotype switch from wild type to SCV only occurs if ATc is contained in the medium; arrows indicate unaffected wild type cells. Scale bar indicates 5 mm.</p></caption><graphic xlink:href="fmicb-10-02044-g004"/></fig><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>Relative patterns of &#x02018;<italic>fabI</italic>&#x02019;-antisense expression in <italic>S. aureus</italic> strains SA113, SAS99/1 (carrying pSN1), and SAS118/2 (carrying pSN1-AS&#x02018;<italic>fabI</italic>&#x02019;) in response to 0.4 &#x003bc;M anhydrotetracycline (ATc). Dashed bars indicate the presence of 0.4 &#x003bc;M ATc, the effector of &#x02018;<italic>fabI</italic>&#x02019;-antisense expression in strains harboring pSN1-AS&#x02018;<italic>fabI</italic>&#x02019;. Normalized expression is shown relative to control SAS99/1 carrying the empty pSN1 (2 h) to exclude chromosomal <italic>fabI</italic> expression.</p></caption><graphic xlink:href="fmicb-10-02044-g005"/></fig><p>Since not all antisense RNA fragments are effective in inhibiting gene expression in <italic>S. aureus</italic> (<xref rid="B33" ref-type="bibr">Ji et al., 2004</xref>), we analyzed several <italic>fabI</italic> fragments from different regions of <italic>fabI</italic> with and without Shine-Dalgarno sequence that exhibited 75- to 300-bp in size, a GC content of 29.3 to 36.7% and &#x00394;<italic>G</italic> values of &#x02212;45.6 to &#x02212;11.8 kcal/mol (for comparison, the 382-bp fragment exhibited a GC content of 34.8% and a &#x00394;G of &#x02212;70.3 kcal/mol; see <xref ref-type="supplementary-material" rid="TS1">Supplementary Material</xref>). However, a silencing effect could only be observed for the 382-bp <italic>fabI</italic> fragment, not for any of the other fragments tested (data not shown) as it could be also not shown before for a fragment bigger than 500 bp (<xref rid="B33" ref-type="bibr">Ji et al., 2004</xref>). Therefore, contrary to expectations, the presence of the Shine-Dalgarno sequence does not seem to be relevant as it was described for gene silencing in <italic>E. coli</italic> (<xref rid="B56" ref-type="bibr">Stefan et al., 2008</xref>). Secondary sequence structure prediction for each fragment revealed different loop regions with unpaired bases that are complementary and with accessible conformation to hybridize with <italic>fabI</italic> mRNA (data not shown). Even though some of these fragments showed loop regions of a bigger size compared to the 382-bp <italic>fabI</italic> fragment, this seemed to have no impact on silencing. Instead, the quantity of loop regions may contribute to silencing, as the 382-bp <italic>fabI</italic> fragment exhibited 20 loops compared to 4 to 16 loops of the other fragments (see <xref ref-type="supplementary-material" rid="TS1">Supplementary Material</xref>). Therefore, antisense silencing seems to depend significantly on fragment size and target region. Thus, the final effectiveness of the fragments is difficult to predict necessitating further examinations.</p></sec><sec id="S4"><title>Conclusion</title><p>Our results demonstrate the crucial role of TetR and its major importance in negative regulation of repressor expression for episomal antisense silencing. However, to perform efficient antisense silencing, size and region of the antisense fragment complementary to the region of the target gene remain critical factors that need further detailed investigations. Plasmid pSN1 allowed antisense silencing of the <italic>fabI</italic> gene in an easy-to-handle one-plasmid setup. Due to the MCS directly downstream of the inducible P<italic><sub><italic>xyl/tet</italic></sub></italic> promoter, genes of interest can easily be cloned into the plasmid. Moreover, the two-<italic>tetO</italic> P<italic><sub><italic>xyl/tet</italic></sub></italic> version exerted a tight repression of the gene of interest in the uninduced state, thus there is no necessity of chromosomal <italic>tetR</italic> integration prior to use. Also other SCV characteristic (e.g., hemolysis behavior, coagulase and protease production, as well as antibiotic resistance) can be analyzed with this system as already shown for antisense silencing of <italic>hla</italic> (encodes for &#x003b1;-toxin) (<xref rid="B32" ref-type="bibr">Ji et al., 1999</xref>). Owing to induction with ATc, pSN1 mediated antisense silencing may not only be applicable to different <italic>S. aureus</italic> backgrounds, but also in cell culture studies (<xref rid="B32" ref-type="bibr">Ji et al., 1999</xref>; <xref rid="B6" ref-type="bibr">Bateman et al., 2001</xref>). Therefore, pSN1 mediated antisense silencing may not only help to identify SCV phenotype-related genes but also to analyse the consequences of the switching process to the host cells and organs.</p></sec><sec sec-type="data-availability" id="S5"><title>Data Availability</title><p>All relevant data for this study are included in the manuscript and/or the <xref ref-type="supplementary-material" rid="TS1">Supplementary Files</xref>.</p></sec><sec id="S6"><title>Author Contributions</title><p>KB and AK designed the study concept. NS, AK, and BB designed the experiments. NS performed the laboratory work, evaluated the data, and drafted and wrote the manuscript. UK contributed to the data evaluation and writing of the manuscript. SF and JS contributed to the laboratory work. RP provided the scientific support regarding SCVs and interpreted the data. All authors have read and approved the final draft of the manuscript.</p></sec><sec id="conf1"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This research was supported in part by a grant to KB (BE 2546/1-2) from the Deutsche Forschungsgemeinschaft (DFG).</p></fn></fn-group><ack><p>We would like to thank Ralph Bertram from the Department of Microbial Genetics, University of T&#x000fc;bingen, T&#x000fc;bingen, Germany for the generous gift of plasmid pRAB11. Furthermore, we are grateful to Melanie Bach and Daniela Kuhn for excellent technical assistance. This manuscript is part of the Ph.D. thesis entitled &#x0201c;<italic>Staphylococcus aureus</italic> Small-Colony Variants &#x02013; Insights in Formation and Antibiotic Susceptibilities&#x0201d; by NS (2019).</p></ack><sec id="S9" sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2019.02044/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2019.02044/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="TS1"><media xlink:href="Table_1.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Qatouseh</surname><given-names>L.</given-names></name><name><surname>Chinni</surname><given-names>S.</given-names></name><name><surname>Seggewi&#x000df;</surname><given-names>J.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><name><surname>Brosius</surname><given-names>J.</given-names></name><name><surname>Rozhdestvensky</surname><given-names>T. S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Identification of differentially expressed small non-protein-coding RNAs in <italic>Staphylococcus aureus</italic> displaying both the normal and the small-colony variant phenotype.</article-title>
<source><italic>J. Mol. Med.</italic></source>
<volume>88</volume>
<fpage>565</fpage>&#x02013;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-010-0597-2</pub-id>
<?supplied-pmid 20151104?><pub-id pub-id-type="pmid">20151104</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>J.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name></person-group> (<year>1990</year>). <article-title>Transformation of <italic>Staphylococcus epidermidis</italic> and other staphylococcal species with plasmid DNA by electroporation.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>66</volume>
<fpage>203</fpage>&#x02013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1990.tb03997.x</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballhausen</surname><given-names>B.</given-names></name><name><surname>Kriegeskorte</surname><given-names>A.</given-names></name><name><surname>Schleimer</surname><given-names>N.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>The <italic>mecA</italic> Homolog <italic>mecC</italic> Confers Resistance against &#x003b2;-Lactams in <italic>Staphylococcus aureus</italic> irrespective of the genetic strain background.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>58</volume>
<fpage>3791</fpage>&#x02013;<lpage>3798</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02731-2713</pub-id><pub-id pub-id-type="pmid">24752255</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balwit</surname><given-names>J. M.</given-names></name><name><surname>van Langevelde</surname><given-names>P.</given-names></name><name><surname>Vann</surname><given-names>J. M.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Gentamicin-resistant menadione and hemin auxotrophic <italic>Staphylococcus aureus</italic> persist within cultured endothelial cells.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>170</volume>
<fpage>1033</fpage>&#x02013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/170.4.1033</pub-id>
<?supplied-pmid 7930701?><pub-id pub-id-type="pmid">7930701</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Band</surname><given-names>L.</given-names></name><name><surname>Yansura</surname><given-names>D. G.</given-names></name><name><surname>Henner</surname><given-names>D. J.</given-names></name></person-group> (<year>1983</year>). <article-title>Construction of a vector for cloning promoters in <italic>Bacillus subtilis</italic>.</article-title>
<source><italic>Gene</italic></source>
<volume>26</volume>
<fpage>313</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(83)90204-90204</pub-id>
<?supplied-pmid 6323271?><pub-id pub-id-type="pmid">6323271</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>B. T.</given-names></name><name><surname>Donegan</surname><given-names>N. P.</given-names></name><name><surname>Jarry</surname><given-names>T. M.</given-names></name><name><surname>Palma</surname><given-names>M.</given-names></name><name><surname>Cheung</surname><given-names>A. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Evaluation of a tetracycline-inducible promoter in <italic>Staphylococcus aureus</italic> in vitro and in vivo and its application in demonstrating the role of <italic>sigB</italic> in microcolony formation.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>69</volume>
<fpage>7851</fpage>&#x02013;<lpage>7857</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.12.7851-7857.2001</pub-id>
<?supplied-pmid 11705967?><pub-id pub-id-type="pmid">11705967</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D. M.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>McNamara</surname><given-names>P. J.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name><name><surname>Yeaman</surname><given-names>M. R.</given-names></name><name><surname>Bayer</surname><given-names>A. S.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title><italic>Staphylococcus aureus menD</italic> and <italic>hemB</italic> mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>187</volume>
<fpage>1654</fpage>&#x02013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1086/374642</pub-id>
<?supplied-pmid 12721946?><pub-id pub-id-type="pmid">12721946</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazaid</surname><given-names>A. S.</given-names></name><name><surname>Forbes</surname><given-names>S.</given-names></name><name><surname>Humphreys</surname><given-names>G. J.</given-names></name><name><surname>Ledder</surname><given-names>R. G.</given-names></name><name><surname>O&#x02019;Cualain</surname><given-names>R.</given-names></name><name><surname>McBain</surname><given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Fatty acid supplementation reverses the small colony variant phenotype in triclosan-adapted <italic>Staphylococcus aureus</italic>: genetic. proteomic and phenotypic analyses.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>3876</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-21925-21926</pub-id>
<?supplied-pmid 29497096?><pub-id pub-id-type="pmid">29497096</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>C. F.</given-names></name><name><surname>Mutzel</surname><given-names>R.</given-names></name><name><surname>Barb&#x000e9;</surname><given-names>J.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>W.</given-names></name></person-group> (<year>1982</year>). <article-title>A multifunctional gene (<italic>tetR</italic>) controls tn10-encoded tetracycline resistance.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>150</volume>
<fpage>633</fpage>&#x02013;<lpage>642</lpage>. <?supplied-pmid 6279565?><pub-id pub-id-type="pmid">6279565</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>Al-Laham</surname><given-names>N.</given-names></name><name><surname>Fegeler</surname><given-names>W.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in <italic>Staphylococcus aureus</italic> small-colony variants.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>44</volume>
<fpage>3274</fpage>&#x02013;<lpage>3278</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00847-846</pub-id>
<?supplied-pmid 16954260?><pub-id pub-id-type="pmid">16954260</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertram</surname><given-names>R.</given-names></name><name><surname>Hillen</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>The application of Tet repressor in prokaryotic gene regulation and expression.</article-title>
<source><italic>Microb. Biotechnol.</italic></source>
<volume>1</volume>
<fpage>2</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2007.00001.x</pub-id>
<?supplied-pmid 21261817?><pub-id pub-id-type="pmid">21261817</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>L. M. G.</given-names></name><name><surname>Hoffmann</surname><given-names>P.</given-names></name><name><surname>Turnidge</surname><given-names>J. D.</given-names></name><name><surname>Zilm</surname><given-names>P. S.</given-names></name><name><surname>Kidd</surname><given-names>S. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Prolonged growth of a clinical <italic>Staphylococcus aureus</italic> strain selects for a stable small-colony-variant cell type.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>83</volume>
<fpage>470</fpage>&#x02013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.02702-2714</pub-id>
<?supplied-pmid 25385795?><pub-id pub-id-type="pmid">25385795</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>L. M. G.</given-names></name><name><surname>Kidd</surname><given-names>S. P.</given-names></name></person-group> (<year>2015</year>). <article-title>A full genomic characterization of the development of a stable small colony variant cell-type by a clinical <italic>Staphylococcus aureus</italic> strain.</article-title>
<source><italic>Infect. Genet. Evol.</italic></source>
<volume>36</volume>
<fpage>345</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/J.MEEGID.2015.10.011</pub-id>
<?supplied-pmid 26458527?><pub-id pub-id-type="pmid">26458527</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>S.</given-names></name><name><surname>Huseby</surname><given-names>D. L.</given-names></name><name><surname>Brandis</surname><given-names>G.</given-names></name><name><surname>Hughes</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Alternative evolutionary pathways for drug-resistant small colony variant mutants in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>mBio</italic></source>
<volume>8</volume>:<issue>e00358-17</issue>. <pub-id pub-id-type="doi">10.1128/mBio.00358-317</pub-id>
<?supplied-pmid 28634236?><pub-id pub-id-type="pmid">28634236</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>I.</given-names></name><name><surname>Kriegeskorte</surname><given-names>A.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Deiwick</surname><given-names>S.</given-names></name><name><surname>Theimann</surname><given-names>N.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>In vivo mutations of thymidylate synthase (encoded by <italic>thyA</italic>) are responsible for thymidine dependency in clinical small-colony variants of <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>190</volume>
<fpage>834</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00912-07</pub-id>
<?supplied-pmid 17905979?><pub-id pub-id-type="pmid">17905979</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>R. M.</given-names></name><name><surname>Foster</surname><given-names>T. J.</given-names></name></person-group> (<year>2009</year>). <article-title>An improved tetracycline-inducible expression vector for <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Plasmid</italic></source>
<volume>61</volume>
<fpage>126</fpage>&#x02013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.plasmid.2008.10.001</pub-id>
<?supplied-pmid 18996145?><pub-id pub-id-type="pmid">18996145</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>M. A.</given-names></name><name><surname>Olsen</surname><given-names>R. J.</given-names></name><name><surname>Long</surname><given-names>S. W.</given-names></name><name><surname>Rosato</surname><given-names>A. E.</given-names></name><name><surname>Musser</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Identification of point mutations in clinical <italic>Staphylococcus aureus</italic> strains that produce small-colony variants auxotrophic for menadione.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>82</volume>
<fpage>1600</fpage>&#x02013;<lpage>1605</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01487-1413</pub-id>
<?supplied-pmid 24452687?><pub-id pub-id-type="pmid">24452687</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degenkolb</surname><given-names>J.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Ellestad</surname><given-names>G. A.</given-names></name><name><surname>Hillen</surname><given-names>W.</given-names></name></person-group> (<year>1991</year>). <article-title>Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>35</volume>
<fpage>1591</fpage>&#x02013;<lpage>1595</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.35.8.1591</pub-id>
<?supplied-pmid 1929330?><pub-id pub-id-type="pmid">1929330</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname><given-names>B. D.</given-names></name><name><surname>Mathew</surname><given-names>A.</given-names></name><name><surname>Satola</surname><given-names>S. W.</given-names></name><name><surname>Shafer</surname><given-names>W. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Altered growth, pigmentation, and antimicrobial susceptibility properties of <italic>Staphylococcus aureus</italic> due to loss of the major cold shock gene <italic>cspB</italic>.</article-title>
<source><italic>Antimicrob. Agents. Chemother.</italic></source>
<volume>54</volume>
<fpage>2283</fpage>&#x02013;<lpage>2290</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01786-1789</pub-id>
<?supplied-pmid 20368405?><pub-id pub-id-type="pmid">20368405</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrt</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>X. V.</given-names></name><name><surname>Hickey</surname><given-names>C. M.</given-names></name><name><surname>Ryou</surname><given-names>M.</given-names></name><name><surname>Monteleone</surname><given-names>M.</given-names></name><name><surname>Riley</surname><given-names>L. W.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>33</volume>:<issue>e21</issue>. <pub-id pub-id-type="doi">10.1093/nar/gni013</pub-id>
<?supplied-pmid 15687379?><pub-id pub-id-type="pmid">15687379</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Chua</surname><given-names>K.</given-names></name><name><surname>Davies</surname><given-names>J. K.</given-names></name><name><surname>Newton</surname><given-names>H. J.</given-names></name><name><surname>Seemann</surname><given-names>T.</given-names></name><name><surname>Harrison</surname><given-names>P. F.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Two novel point mutations in clinical <italic>Staphylococcus aureus</italic> reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>6</volume>:<issue>e1000944</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000944</pub-id>
<?supplied-pmid 20548948?><pub-id pub-id-type="pmid">20548948</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaupp</surname><given-names>R.</given-names></name><name><surname>Schlag</surname><given-names>S.</given-names></name><name><surname>Liebeke</surname><given-names>M.</given-names></name><name><surname>Lalk</surname><given-names>M.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Advantage of upregulation of succinate dehydrogenase in <italic>Staphylococcus aureus</italic> Biofilm.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>192</volume>
<fpage>2385</fpage>&#x02013;<lpage>2394</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01472-1479</pub-id>
<?supplied-pmid 20207757?><pub-id pub-id-type="pmid">20207757</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissend&#x000f6;rfer</surname><given-names>M.</given-names></name><name><surname>Hillen</surname><given-names>W.</given-names></name></person-group> (<year>1990</year>). <article-title>Regulated expression of heterologous genes in <italic>Bacillus subtilis</italic> using the Tn<italic>10</italic> encoded <italic>tet</italic> regulatory elements.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>33</volume>
<fpage>657</fpage>&#x02013;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1007/BF00604933</pub-id>
<?supplied-pmid 1369298?><pub-id pub-id-type="pmid">1369298</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giulieri</surname><given-names>S. G.</given-names></name><name><surname>Baines</surname><given-names>S. L.</given-names></name><name><surname>Guerillot</surname><given-names>R.</given-names></name><name><surname>Seemann</surname><given-names>T.</given-names></name><name><surname>Gon&#x000e7;alves da Silva</surname><given-names>A.</given-names></name><name><surname>Schultz</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent <italic>Staphylococcus aureus</italic> bacteraemia.</article-title>
<source><italic>Genome. Med.</italic></source>
<volume>10</volume>:<issue>65</issue>. <pub-id pub-id-type="doi">10.1186/s13073-018-0574-x</pub-id>
<?supplied-pmid 30103826?><pub-id pub-id-type="pmid">30103826</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>N. D.</given-names></name><name><surname>Reniere</surname><given-names>M. L.</given-names></name><name><surname>Cassat</surname><given-names>J. E.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Hirsch</surname><given-names>A. O.</given-names></name><name><surname>Indriati Hood</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Two heme-dependent terminal oxidases power <italic>Staphylococcus aureus</italic> organ-specific colonization of the vertebrate host.</article-title>
<source><italic>mBio</italic></source>
<volume>4</volume>:<issue>e00241-13</issue>. <pub-id pub-id-type="doi">10.1128/mBio.00241-213</pub-id>
<?supplied-pmid 23900169?><pub-id pub-id-type="pmid">23900169</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name></person-group> (<year>1983</year>). <article-title>Studies on Transformation of <italic>Escherichia coli</italic> with plasmids.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>166</volume>
<fpage>557</fpage>&#x02013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(83)80284-80288</pub-id>
<?supplied-pmid 6345791?><pub-id pub-id-type="pmid">6345791</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helle</surname><given-names>L.</given-names></name><name><surname>Kull</surname><given-names>M.</given-names></name><name><surname>Mayer</surname><given-names>S.</given-names></name><name><surname>Marincola</surname><given-names>G.</given-names></name><name><surname>Zelder</surname><given-names>M.-E.</given-names></name><name><surname>Goerke</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Vectors for improved Tet repressor-dependent gradual gene induction or silencing in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Microbiology</italic></source>
<volume>157</volume>
<fpage>3314</fpage>&#x02013;<lpage>3323</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.052548-0</pub-id>
<?supplied-pmid 21921101?><pub-id pub-id-type="pmid">21921101</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>S.</given-names></name><name><surname>Ziebandt</surname><given-names>A.-K.</given-names></name><name><surname>Ohlsen</surname><given-names>K.</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>T.</given-names></name><name><surname>Hecker</surname><given-names>M.</given-names></name><name><surname>Albrecht</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Repair of global regulators in <italic>Staphylococcus aureus</italic> 8325 and comparative analysis with other clinical isolates.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>78</volume>
<fpage>2877</fpage>&#x02013;<lpage>2889</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00088-10</pub-id>
<?supplied-pmid 20212089?><pub-id pub-id-type="pmid">20212089</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iordanescu</surname><given-names>S.</given-names></name><name><surname>Surdeanu</surname><given-names>M.</given-names></name></person-group> (<year>1976</year>). <article-title>Two restriction and modification systems in <italic>Staphylococcus aureus</italic> NCTC8325.</article-title>
<source><italic>J. Gen. Microbiol.</italic></source>
<volume>96</volume>
<fpage>277</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-96-2-277</pub-id>
<?supplied-pmid 136497?><pub-id pub-id-type="pmid">136497</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>K. L.</given-names></name><name><surname>Mogen</surname><given-names>A. B.</given-names></name><name><surname>Brandwein</surname><given-names>J. N.</given-names></name><name><surname>Orsini</surname><given-names>S. S.</given-names></name><name><surname>Ridder</surname><given-names>M. J.</given-names></name><name><surname>Markiewicz</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Interplay of nitric oxide synthase (NOS) and SrrAB in modulation of <italic>Staphylococcus aureus</italic> metabolism and virulence.</article-title>
<source><italic>Infec. Immun.</italic></source>
<volume>87</volume>:<issue>e00570-18</issue>. <pub-id pub-id-type="doi">10.1128/IAI.00570-18</pub-id>
<?supplied-pmid 30420450?><pub-id pub-id-type="pmid">30420450</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>M.</given-names></name><name><surname>Luong</surname><given-names>T.-T.</given-names></name><name><surname>Komatsuzawa</surname><given-names>H.</given-names></name><name><surname>Shigeta</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>C. Y.</given-names></name></person-group> (<year>2000</year>). <article-title>A method for demonstrating gene essentiality in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Plasmid</italic></source>
<volume>44</volume>
<fpage>100</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1006/PLAS.2000.1473</pub-id>
<?supplied-pmid 10873532?><pub-id pub-id-type="pmid">10873532</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Marra</surname><given-names>A.</given-names></name><name><surname>Rosenberg</surname><given-names>M.</given-names></name><name><surname>Woodnutt</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>Regulated antisense RNA eliminates alpha-toxin virulence in <italic>Staphylococcus aureus</italic> infection.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>181</volume>
<fpage>6585</fpage>&#x02013;<lpage>6590</lpage>. <?supplied-pmid 10542157?><pub-id pub-id-type="pmid">10542157</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>D.</given-names></name><name><surname>Fox</surname><given-names>B.</given-names></name><name><surname>Holmes</surname><given-names>D. J.</given-names></name><name><surname>Payne</surname><given-names>D.</given-names></name><name><surname>Rosenberg</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Validation of antibacterial mechanism of action using regulated antisense RNA expression in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>231</volume>
<fpage>177</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1097(03)00931-935</pub-id>
<?supplied-pmid 14987762?><pub-id pub-id-type="pmid">14987762</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahl</surname><given-names>B. C.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>L&#x000f6;ffler</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Clinical Significance and pathogenesis of <italic>Staphylococcal</italic> small colony variants in persistent infections.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>29</volume>
<fpage>401</fpage>&#x02013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00069-15</pub-id>
<?supplied-pmid 26960941?><pub-id pub-id-type="pmid">26960941</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;ser</surname><given-names>C. U.</given-names></name><name><surname>Holden</surname><given-names>M. T. G.</given-names></name><name><surname>Ellington</surname><given-names>M. J.</given-names></name><name><surname>Cartwright</surname><given-names>E. J. P.</given-names></name><name><surname>Brown</surname><given-names>N. M.</given-names></name><name><surname>Ogilvy-Stuart</surname><given-names>A. L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>366</volume>
<fpage>2267</fpage>&#x02013;<lpage>2275</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1109910</pub-id>
<?supplied-pmid 22693998?><pub-id pub-id-type="pmid">22693998</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriegeskorte</surname><given-names>A.</given-names></name><name><surname>Grubm&#x000fc;ller</surname><given-names>S.</given-names></name><name><surname>Huber</surname><given-names>C.</given-names></name><name><surname>Kahl</surname><given-names>B. C.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title><italic>Staphylococcus aureus</italic> small colony variants show common metabolic features in central metabolism irrespective of the underlying auxotrophism.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>4</volume>:<issue>414</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2014.00141</pub-id>
<?supplied-pmid 25374845?><pub-id pub-id-type="pmid">25374845</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriegeskorte</surname><given-names>A.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>S.</given-names></name><name><surname>Sander</surname><given-names>G.</given-names></name><name><surname>Pirkl</surname><given-names>A.</given-names></name><name><surname>Mahabir</surname><given-names>E.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Small colony variants of <italic>Staphylococcus aureus</italic> reveal distinct protein profiles.</article-title>
<source><italic>Proteomics</italic></source>
<volume>11</volume>
<fpage>2476</fpage>&#x02013;<lpage>2490</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201000796</pub-id>
<?supplied-pmid 21595038?><pub-id pub-id-type="pmid">21595038</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lannerg&#x000e5;rd</surname><given-names>J.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>Sander</surname><given-names>G.</given-names></name><name><surname>Cordes</surname><given-names>T.</given-names></name><name><surname>Seggewi&#x000df;</surname><given-names>J.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>52</volume>
<fpage>4017</fpage>&#x02013;<lpage>4022</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00668-668</pub-id>
<?supplied-pmid 18779359?><pub-id pub-id-type="pmid">18779359</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.-T.</given-names></name><name><surname>Tsai</surname><given-names>J.-C.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>H.-J.</given-names></name><name><surname>Hung</surname><given-names>W.-C.</given-names></name><name><surname>Hsueh</surname><given-names>P.-R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Emergence of a small colony variant of vancomycin-intermediate <italic>Staphylococcus aureus</italic> in a patient with septic arthritis during long-term treatment with daptomycin.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>71</volume>
<fpage>1807</fpage>&#x02013;<lpage>1814</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkw060</pub-id>
<?supplied-pmid 26968883?><pub-id pub-id-type="pmid">26968883</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>R.</given-names></name><name><surname>Bujard</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Independent and tight regulation of transcriptional units in <italic>Escherichia coli</italic> via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>25</volume>
<fpage>1203</fpage>&#x02013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1093/nar/25.6.1203</pub-id>
<?supplied-pmid 9092630?><pub-id pub-id-type="pmid">9092630</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>K.</given-names></name><name><surname>Holmes</surname><given-names>E. A.</given-names></name><name><surname>Penewit</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>D. K.</given-names></name><name><surname>Hardy</surname><given-names>S. R.</given-names></name><name><surname>Ren</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Artificial selection for pathogenicity mutations in <italic>Staphylococcus aureus</italic> identifies novel factors relevant to chronic infection.</article-title>
<source><italic>Infec. Immun.</italic></source>
<volume>87</volume> e00884-18. <pub-id pub-id-type="doi">10.1128/IAI.00884-818</pub-id>
<?supplied-pmid 30642903?><pub-id pub-id-type="pmid">30642903</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>I.</given-names></name><name><surname>Wray</surname><given-names>L. V.</given-names></name><name><surname>Hillen</surname><given-names>W.</given-names></name></person-group> (<year>1988</year>). <article-title>Differential regulation of the Tn<italic>10</italic>-encoded tetracycline resistance genes <italic>tetA</italic> and <italic>tetR</italic> by the tandem <italic>tet</italic> operators O1 and O2.</article-title>
<source><italic>EMBO J.</italic></source>
<volume>7</volume>
<fpage>567</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1002/J.1460-2075.1988.TB02846.X</pub-id>
<?supplied-pmid 2835235?><pub-id pub-id-type="pmid">2835235</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>G.</given-names></name><name><surname>Fug&#x000e8;re</surname><given-names>A.</given-names></name><name><surname>P&#x000e9;pin Gaudreau</surname><given-names>K.</given-names></name><name><surname>Brouillette</surname><given-names>E.</given-names></name><name><surname>Frost</surname><given-names>E. H.</given-names></name><name><surname>Cantin</surname><given-names>A. M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>SigB Is a dominant regulator of virulence in <italic>Staphylococcus aureus</italic> small-colony variants.</article-title>
<source><italic>PLoS One.</italic></source>
<volume>8</volume>:<issue>e65018</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0065018</pub-id>
<?supplied-pmid 23705029?><pub-id pub-id-type="pmid">23705029</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moisan</surname><given-names>H.</given-names></name><name><surname>Brouillette</surname><given-names>E.</given-names></name><name><surname>Jacob</surname><given-names>C. L.</given-names></name><name><surname>Langlois-B&#x000e9;gin</surname><given-names>P.</given-names></name><name><surname>Michaud</surname><given-names>S.</given-names></name><name><surname>Malouin</surname><given-names>F.</given-names></name></person-group> (<year>2006</year>). <article-title>Transcription of virulence factors in <italic>Staphylococcus aureus</italic> small-colony variants isolated from cystic fibrosis patients is influenced by SigB.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>188</volume>
<fpage>64</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1128/JB.188.1.64-76.2006</pub-id>
<?supplied-pmid 16352822?><pub-id pub-id-type="pmid">16352822</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname><given-names>R.</given-names></name></person-group> (<year>1967</year>). <article-title>Properties of a cryptic high-frequency transducing phage in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Virology</italic></source>
<volume>33</volume>
<fpage>155</fpage>&#x02013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/0042-6822(67)90105-90105</pub-id><pub-id pub-id-type="pmid">4227577</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname><given-names>K. L.</given-names></name><name><surname>Strange</surname><given-names>E.</given-names></name><name><surname>Parkhill</surname><given-names>J.</given-names></name><name><surname>Bamford</surname><given-names>K. B.</given-names></name><name><surname>Armstrong-James</surname><given-names>D.</given-names></name><name><surname>Edwards</surname><given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Staphylococcus aureus</italic> adapts to oxidative stress by producing H<sub>2</sub>O<sub>2</sub>-resistant small-colony variants via the SOS response.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>83</volume>
<fpage>1830</fpage>&#x02013;<lpage>1844</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.03016-3014</pub-id>
<?supplied-pmid 25690100?><pub-id pub-id-type="pmid">25690100</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>J. B.</given-names></name><name><surname>Frank</surname><given-names>M. W.</given-names></name><name><surname>Jackson</surname><given-names>P.</given-names></name><name><surname>Subramanian</surname><given-names>C.</given-names></name><name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>2014</year>). <article-title>Incorporation of extracellular fatty acids by a fatty acid kinase-dependent pathway in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Mol. Microbiol.</italic></source>
<volume>92</volume>
<fpage>234</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12556</pub-id>
<?supplied-pmid 24673884?><pub-id pub-id-type="pmid">24673884</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>J. B.</given-names></name><name><surname>Frank</surname><given-names>M. W.</given-names></name><name><surname>Rosch</surname><given-names>J. W.</given-names></name><name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Staphylococcus aureus</italic> fatty acid auxotrophs do not proliferate in mice.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>57</volume>
<fpage>5729</fpage>&#x02013;<lpage>5732</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01038-1013</pub-id><pub-id pub-id-type="pmid">23979734</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>J. B.</given-names></name><name><surname>Frank</surname><given-names>M. W.</given-names></name><name><surname>Subramanian</surname><given-names>C.</given-names></name><name><surname>Saenkham</surname><given-names>P.</given-names></name><name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>2011</year>). <article-title>Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>108</volume>
<fpage>15378</fpage>&#x02013;<lpage>15383</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1109208108</pub-id>
<?supplied-pmid 21876172?><pub-id pub-id-type="pmid">21876172</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>R. A.</given-names></name><name><surname>Kriegeskorte</surname><given-names>A.</given-names></name><name><surname>Kahl</surname><given-names>B. C.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>L&#x000f6;ffler</surname><given-names>B.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Staphylococcus aureus</italic> small colony variants (SCVs): a road map for the metabolic pathways involved in persistent infections.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>4</volume>:<issue>99</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2014.00099</pub-id>
<?supplied-pmid 25120957?><pub-id pub-id-type="pmid">25120957</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>R. A.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>Kahl</surname><given-names>B. C.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>McNamara</surname><given-names>P.</given-names></name><name><surname>Herrmann</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>4</volume>
<fpage>295</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1384</pub-id>
<?supplied-pmid 16541137?><pub-id pub-id-type="pmid">16541137</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaaff</surname><given-names>F.</given-names></name><name><surname>Bierbaum</surname><given-names>G.</given-names></name><name><surname>Baumert</surname><given-names>N.</given-names></name><name><surname>Bartmann</surname><given-names>P.</given-names></name><name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group> (<year>2003</year>). <article-title>Mutations are involved in emergence of aminoglycoside-induced small colony variants of <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Int. J. Med. Microbiol.</italic></source>
<volume>293</volume>
<fpage>427</fpage>&#x02013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1078/1438-4221-00282</pub-id>
<?supplied-pmid 14760974?><pub-id pub-id-type="pmid">14760974</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleimer</surname><given-names>N.</given-names></name><name><surname>Kaspar</surname><given-names>U.</given-names></name><name><surname>Drescher</surname><given-names>M.</given-names></name><name><surname>Seggewi&#x000df;</surname><given-names>J.</given-names></name><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>Proctor</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The energy-coupling factor transporter module EcfAA&#x02019;T, a novel candidate for the genetic basis of fatty acid-auxotrophic small-colony variants of <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>9</volume>:<issue>1863</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.01863</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seggewi&#x000df;</surname><given-names>J.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>Kotte</surname><given-names>O.</given-names></name><name><surname>Eisenacher</surname><given-names>M.</given-names></name><name><surname>Yazdi</surname><given-names>M. R. K.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Reporter metabolite analysis of transcriptional profiles of a <italic>Staphylococcus aureus</italic> strain with normal phenotype and its isogenic <italic>hemB</italic> mutant displaying the small-colony-variant phenotype.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>188</volume>
<fpage>7765</fpage>&#x02013;<lpage>7777</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00774-776</pub-id>
<?supplied-pmid 16980462?><pub-id pub-id-type="pmid">16980462</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stary</surname><given-names>E.</given-names></name><name><surname>Gaupp</surname><given-names>R.</given-names></name><name><surname>Lechner</surname><given-names>S.</given-names></name><name><surname>Leibig</surname><given-names>M.</given-names></name><name><surname>Tichy</surname><given-names>E.</given-names></name><name><surname>Kolb</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>New architectures for Tet-on and Tet-off regulation in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>76</volume>
<fpage>680</fpage>&#x02013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02416-09</pub-id>
<?supplied-pmid 19966017?><pub-id pub-id-type="pmid">19966017</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefan</surname><given-names>A.</given-names></name><name><surname>Tonelli</surname><given-names>A.</given-names></name><name><surname>Schwarz</surname><given-names>F.</given-names></name><name><surname>Hochkoeppler</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Artificial antisense RNAs silence <italic>lacZ</italic> in <italic>E. coli</italic> by decreasing target mRNA concentration.</article-title>
<source><italic>BMB Rep.</italic></source>
<volume>41</volume>
<fpage>568</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.5483/bmbrep.2008.41.8.568</pub-id>
<?supplied-pmid 18755071?><pub-id pub-id-type="pmid">18755071</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tinsley</surname><given-names>E.</given-names></name><name><surname>Khan</surname><given-names>S. A.</given-names></name></person-group> (<year>2007</year>). <article-title>A <italic>Bacillus anthracis</italic>-based in vitro system supports replication of plasmid pXO2 as well as rolling-circle-replicating plasmids.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>73</volume>
<fpage>5005</fpage>&#x02013;<lpage>5010</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00240-07</pub-id>
<?supplied-pmid 17575005?><pub-id pub-id-type="pmid">17575005</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuchscherr</surname><given-names>L.</given-names></name><name><surname>Bischoff</surname><given-names>M.</given-names></name><name><surname>Lattar</surname><given-names>S. M.</given-names></name><name><surname>Noto Llana</surname><given-names>M.</given-names></name><name><surname>Pf&#x000f6;rtner</surname><given-names>H.</given-names></name><name><surname>Niemann</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Sigma factor <italic>SigB</italic> is crucial to mediate <italic>Staphylococcus aureus</italic> adaptation during chronic infections.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>11</volume>:<issue>e1004870</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004870</pub-id>
<?supplied-pmid 25923704?><pub-id pub-id-type="pmid">25923704</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuchscherr</surname><given-names>L.</given-names></name><name><surname>Medina</surname><given-names>E.</given-names></name><name><surname>Hussain</surname><given-names>M.</given-names></name><name><surname>V&#x000f6;lker</surname><given-names>W.</given-names></name><name><surname>Heitmann</surname><given-names>V.</given-names></name><name><surname>Niemann</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title><italic>Staphylococcus aureus</italic> phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection.</article-title>
<source><italic>EMBO Mol. Med.</italic></source>
<volume>3</volume>
<fpage>129</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201000115</pub-id>
<?supplied-pmid 21268281?><pub-id pub-id-type="pmid">21268281</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaudaux</surname><given-names>P.</given-names></name><name><surname>Kelley</surname><given-names>W. L.</given-names></name><name><surname>Lew</surname><given-names>D. P.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>Staphylococcus aureus</italic> small colony variants: difficult to diagnose and difficult to treat.</article-title>
<source><italic>Clin. Infect. Dis.</italic></source>
<volume>43</volume>
<fpage>968</fpage>&#x02013;<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1086/507643</pub-id>
<?supplied-pmid 16983606?><pub-id pub-id-type="pmid">16983606</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestergaard</surname><given-names>M.</given-names></name><name><surname>N&#x000f8;hr-Meldgaard</surname><given-names>K.</given-names></name><name><surname>Ingmer</surname><given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Int. J. Antimicrob. Agents.</italic></source>
<volume>51</volume>
<fpage>132</fpage>&#x02013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/J.IJANTIMICAG.2017.08.024</pub-id>
<?supplied-pmid 28843820?><pub-id pub-id-type="pmid">28843820</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Eiff</surname><given-names>C.</given-names></name><name><surname>Heilmann</surname><given-names>C.</given-names></name><name><surname>Proctor</surname><given-names>R.</given-names></name><name><surname>Woltz</surname><given-names>C.</given-names></name><name><surname>Peters</surname><given-names>G.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>A site-directed <italic>Staphylococcus aureus hemB</italic> Mutant is a small-colony variant which persists intracellularly.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>179</volume>
<fpage>4706</fpage>&#x02013;<lpage>4712</lpage>. <pub-id pub-id-type="doi">10.1128/jb.179.15.4706-4712.1997</pub-id>
<?supplied-pmid 9244256?><pub-id pub-id-type="pmid">9244256</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakeman</surname><given-names>C. A.</given-names></name><name><surname>Hammer</surname><given-names>N. D.</given-names></name><name><surname>Stauff</surname><given-names>D. L.</given-names></name><name><surname>Attia</surname><given-names>A. S.</given-names></name><name><surname>Anzaldi</surname><given-names>L. L.</given-names></name><name><surname>Dikalov</surname><given-names>S. I.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Menaquinone biosynthesis potentiates haem toxicity in <italic>Staphylococcus aureus</italic>.</article-title>
<source><italic>Mol. Microbiol.</italic></source>
<volume>86</volume>
<fpage>1376</fpage>&#x02013;<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12063</pub-id>
<?supplied-pmid 23043465?><pub-id pub-id-type="pmid">23043465</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieland</surname><given-names>K.-P.</given-names></name><name><surname>Wieland</surname><given-names>B.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name></person-group> (<year>1995</year>). <article-title>A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for <italic>Staphylococcus carnosus</italic>.</article-title>
<source><italic>Gene</italic></source>
<volume>158</volume>
<fpage>91</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(95)00137-U</pub-id>
<?supplied-pmid 7789818?><pub-id pub-id-type="pmid">7789818</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wissmann</surname><given-names>A.</given-names></name><name><surname>Meier</surname><given-names>I.</given-names></name><name><surname>Hillen</surname><given-names>W.</given-names></name></person-group> (<year>1988</year>). <article-title>Saturation mutagenesis of the Tn<italic>10</italic>-encoded <italic>tet</italic> operator O1: identification of base-pairs involved in Tet repressor recognition.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>202</volume>
<fpage>397</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(88)90273-2</pub-id>
<?supplied-pmid 2845099?><pub-id pub-id-type="pmid">2845099</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.-L.</given-names></name><name><surname>Zubay</surname><given-names>G.</given-names></name><name><surname>Levy</surname><given-names>S. B.</given-names></name></person-group> (<year>1976</year>). <article-title>Synthesis of an R plasmid protein associated with tetracycline resistance is negatively regulated.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>73</volume>
<fpage>1509</fpage>&#x02013;<lpage>1512</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.73.5.1509</pub-id>
<?supplied-pmid 775491?><pub-id pub-id-type="pmid">775491</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>F.</given-names></name><name><surname>Palmer</surname><given-names>L. M.</given-names></name><name><surname>Lonetto</surname><given-names>M. A.</given-names></name><name><surname>Petit</surname><given-names>C.</given-names></name><name><surname>Voelker</surname><given-names>L. L.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Regulated gene expression in <italic>Staphylococcus aureus</italic> for identifying conditional lethal phenotypes and antibiotic mode of action.</article-title>
<source><italic>Gene</italic></source>
<volume>255</volume>
<fpage>297</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(00)00325-325</pub-id>
<?supplied-pmid 11024290?><pub-id pub-id-type="pmid">11024290</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wright</surname><given-names>J. A.</given-names></name><name><surname>Osman</surname><given-names>A. A.</given-names></name><name><surname>Nair</surname><given-names>S. P.</given-names></name></person-group> (<year>2017</year>). <article-title>An <italic>aroD</italic> Ochre mutation results in a <italic>Staphylococcus aureus</italic> small colony variant that can undergo phenotypic switching via two alternative mechanisms.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>8</volume>:<issue>1001</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01001</pub-id>
<?supplied-pmid 28620368?><pub-id pub-id-type="pmid">28620368</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuker</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Mfold web server for nucleic acid folding and hybridization prediction.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>31</volume>
<fpage>3406</fpage>&#x02013;<lpage>3415</lpage>. <pub-id pub-id-type="doi">10.1093/NAR/GKG595</pub-id>
<?supplied-pmid 12824337?><pub-id pub-id-type="pmid">12824337</pub-id></mixed-citation></ref></ref-list></back></article>